Medicines Co. (MDCO) Misses Q1 EPS by 20c

Medicines Co. (NASDAQ: MDCO) reported Q1 EPS of ($1.44), $0.20 worse than the analyst estimate of ($1.24). Revenue for the quarter came in at $24.2 million versus the consensus estimate of $34.08 million.

For earnings history and earnings-related data on Medicines Co. (MDCO) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Opera Limited (OPRA) Misses Q2 EPS by 1c ; Offers Guidance
• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics